Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Mol Genet Metab ; 90(4): 449-52, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17270480

RESUMEN

The enzymatic defect in Pompe disease is insufficient lysosomal acid alpha-glucosidase (GAA) activity which leads to lysosomal glycogen accumulation. We recently introduced a simple and reliable method to measure GAA activity in dried blood spots using Acarbose, a highly selective alpha-glucosidase inhibitor, to eliminate isoenzyme interference. Here we demonstrate that this method efficiently detects late-onset Pompe patients who are frequently misdiagnosed by conventional methods due to residual GAA activity in other tissue types.


Asunto(s)
Enfermedad del Almacenamiento de Glucógeno Tipo II/diagnóstico , alfa-Glucosidasas/sangre , Acarbosa/farmacología , Adulto , Recolección de Muestras de Sangre/métodos , Células Cultivadas , Fibroblastos/enzimología , Fluorometría/métodos , Inhibidores de Glicósido Hidrolasas , Humanos , Himecromona/análogos & derivados , Himecromona/metabolismo , Isoenzimas/sangre , Especificidad por Sustrato
3.
Genet Med ; 8(5): 302-6, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16702880

RESUMEN

PURPOSE: The study's purpose was to compare acarbose and maltose as inhibitors of maltase-glucoamylase activity for determining acid alpha-glucosidase activity in dried blood spot specimens for early identification of patients with infantile Pompe disease, a severe form of acid alpha-glucosidase deficiency. METHODS: Acid alpha-glucosidase activities in dried blood spot extracts were determined fluorometrically using the artificial substrate 4-methylumbelliferyl-alpha-D-pyranoside. Acarbose or maltose was used to inhibit maltase-glucoamylase, an enzyme present in polymorphonuclear neutrophils that contributes to the total alpha-glucosidase activity at acidic pH. RESULTS: Complete discrimination between patients with proven infantile Pompe disease (n = 20), obligate heterozygotes (n = 16), and controls (n = 150) was achieved using 8 micromol/L acarbose as the inhibitor. Higher acarbose concentration (80 micromol/L) did not improve the assay. By using 4 mM maltose as the inhibitor, heterozygotes and patients were not completely separated. The results using acarbose compared well with those using the skin fibroblast assay in the same group of patients with proven infantile Pompe disease. CONCLUSION: Acid alpha-glucosidase activity measurements in dried blood spot extracts can reliably detect infantile Pompe disease in patients. The convenience of collecting and shipping dried blood specimens plus rapid turnaround time makes this assay an attractive alternative to established methods.


Asunto(s)
Pruebas Enzimáticas Clínicas/métodos , Inhibidores Enzimáticos , Enfermedad del Almacenamiento de Glucógeno Tipo II/diagnóstico , Inhibidores de Glicósido Hidrolasas , Acarbosa/farmacología , Adulto , Heterocigoto , Humanos , Concentración de Iones de Hidrógeno , Recién Nacido , Maltosa/farmacología , alfa-Glucosidasas/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA